Form 8-K - Current report:
SEC Accession No. 0000950170-25-036829
Filing Date
2025-03-11
Accepted
2025-03-11 07:35:07
Documents
14
Period of Report
2025-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agen-20250311.htm   iXBRL 8-K 40288
2 EX-99.1 agen-ex99_1.htm EX-99.1 24500
3 GRAPHIC img250783414_0.jpg GRAPHIC 76634
4 GRAPHIC img250783414_1.gif GRAPHIC 43
  Complete submission text file 0000950170-25-036829.txt   286381

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20250311.xsd EX-101.SCH 23893
16 EXTRACTED XBRL INSTANCE DOCUMENT agen-20250311_htm.xml XML 4505
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 25725864
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)